FDA approves first microbiome therapeutic for C. diff infection in adults
On April 26, the U.S. Food and Drug Administration (FDA) approved the first investigational microbiome therapeutic for treating recurrent Clostridioides difficile infection in adults. …
FDA approves first microbiome therapeutic for C. diff infection in adults Read More »